 |
Obesity in perspective.
|
 |
The causes for obesity. |
 |
Clinical and field methods to estimate obesity. |
|
A. Obesity by body weight. |
|
B. Obesity by fat content. |
|
C. Methods to estimate body fat content. |
 |
Prevalence of obesity.
|
 |
Incidence of obesity. |
 |
Clinical complications of obesity. |
 |
The struggles of obese individuals: |
| |
A. Combating the "yo-yo" syndrome. |
| |
B. Fighting their natural tendency to retain the weight. |
| |
C. The health risk of being overweight. |
| |
D. Discrimination. |
| |
E. Loss of self esteem. |
 |
Weight control programs: Why did we not reach our goal? |
 |
Adipose tissue metabolism: An overview. |
 |
Nature vs. nurture. |
 |
Physical activity and obesity. |
 |
A
multifactorial model to explain the genesis of obesity. |
 |
The hypothalamus as the end organ in the genesis of obesity.
|
 |
Autonomic Nervous System and Obesity. |
 |
Endocrine system and Obesity. |
 |
The treatment of obesity: Are we unjustly blaming obese subjects
for their lack of will power to struggle against their disease? |
| |
 |
The hCG (Human Choriogonadotropin) method for weight loss:
overcoming the "test of time". |
 |
Bibliography. |
 |
Metropolitan height-weight. |
 |
Tables. |
 |
The oral hCG (Human Choriogonadotropin) method for
the treatment of obesity. |
 |
History The pharmacologic nature of hCG. |
 |
A
word of caution for those interested in the hCG method for obesity
treatment. |
 |
Mechanisms of action. |
 |
An interesting combined procedure: hCG protocol plus selective
local adrenergic modulation of adipose tissue metabolism. |
| |
 |
Oral hCG (Human Choriogonadotropin) for the management of obesity:
a Double-Blind study. |
 |
The oral technique: hCG preparation. |
 |
First consultation with the patient. |
 |
Lab tests. |
 |
Starting the treatment. |
 |
Follow-up. |
 |
Maintenance period. |
 |
Frequently Asked Questions. |